Indicator Report Data View Options
Why Is This Important?
Esophageal cancer occurs in the esophagus, which is the tube connecting your throat to your stomach. Esophageal cancer usually begins in the cells lining the inside of the esophagus and grows outward. Each year, esophageal cancer accounts for around 1% of all new cancer cases and 2.7% of all cancer deaths in the U.S. This equates to approximately 20,640 cases and 16,410 deaths. The five-year survival rate is 20.6%.
Esophageal cancer incidence refers to the number of persons newly diagnosed with esophageal cancer during a specified time period. Measures include 1) Number of newly diagnosed esophageal cancer cases; and 2) Age-adjusted esophageal cancer incidence rates per 100,000 population.
Data NotesRates have been age-adjusted using the direct method and the 2000 U.S. standard population.
How the Measure is Calculated
Numerator:The number of esophageal cancer cases newly diagnosed in New Mexico residents within a specified time period.
Denominator:The estimated population of New Mexico residents within a specified time period.
New Mexico Population Estimates
All population estimates apply to July 1 of the selected year. These estimates are considered the most accurate estimates for the state of New Mexico and should match those found on the University of New Mexico Geospatial and Population Studies website. Estimates include decimal fractions. Census tract population estimates were summed to produce County and Small Area population estimates. Population estimate totals may vary due to rounding. Population estimates for previous years are occasionally revised as new information becomes available. When publishing trend data, always be sure that your rates for earlier years match current rates on NM-IBIS that have been calculated with the most up-to-date population estimates.
New Mexico Tumor Registry
In agreement with the New Mexico Tumor Registry, to ensure confidentiality the count of cancer cases is suppressed for any given county if the count is between one and four and the population is less than 1,000. NOTE: The COVID-19 pandemic disrupted health services, leading to delays and reductions in cancer screening, diagnosis, and reporting to some central cancer registries. This may have contributed to an observed decline in 2020 incidence for most cancer sites.